SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is currently the focus of intense investor scrutiny as shareholders, led by activist investor Shah Capital, escalate pressure on the board to address stagnant stock performance and executive compensation ahead of the upcoming June shareholder meeting. The community is actively debating the company's long-term potential, with bullish sentiment anchored in the proprietary Matrix-M adjuvant technology and potential oncology applications, while bearish voices remain focused on management's lack of transparency and failure to monetize key assets like the COVID-influenza combination vaccine.

Tidal Trust II - YieldMax COIN Option Income Strategy ETF

YieldMax COIN Option Income Strategy ETF

Investors in the YieldMax COIN Option Income Strategy ETF (CONY) are actively debating the merits of a 'hold and harvest' strategy, highlighting the fund's role as a monthly cash flow engine despite concerns over NAV erosion. The community is heavily focused on the trade-off between collecting high-yield distributions and the long-term impact on principal, with many shareholders emphasizing the importance of reinvestment to build share count and lower cost basis over time.

Spdr Dow Jones Industrial Average ETF Trust - Spdr Dow Jones Industrial Average ETF Trust

The SPDR Dow Jones Industrial Average ETF (DIA) is currently at the center of market discussions as investors react to geopolitical instability surrounding U.S.-Iran negotiations and a flurry of high-level diplomatic meetings. The community is actively debating the sustainability of current record-high market valuations against a backdrop of sticky inflation, elevated Treasury yields, and skepticism regarding the long-term impact of AI-driven capital expenditure.

CPS Technologies Corp. engages in the provision of advanced material solutions to the transportation, automotive, energy, computing or Internet, telecommunications, aerospace, defense, and oil and gas end markets. The firm focuses on the design, manufacture, and sale of custom metal matrix composite components. It also assembles housings and packages for hybrid circuit. The company was founded in 1984 and is headquartered in Norton, MA.

CPS Technologies Corporation

CPS Technologies is drawing investor interest driven by strong manufacturing potential in the aerospace and defense sectors, specifically around its proprietary metal-matrix composites and tungsten-based products. The community is actively speculating about the timing of major commercial orders, particularly regarding potential supply chain ties to high-growth aerospace firms.

Nasdaq, Inc. is a holding company, which engages in trading, clearing, exchange technology, regulatory, securities listing, information, and public and private company services. It operates through the following segments: Capital Access Platforms, Financial Technology, and Market Services. The Capital Access Platforms segment delivers liquidity, transparency, and integrity to the corporate issuer and investment community by empowering clients to effectively navigate the capital markets, achieve their sustainability goals, and drive governance excellence. The Financial Technology segment offers platforms that improve the liquidity, transparency, and integrity of the global economy by architecting and operating the markets. The Market Services segment includes equity derivative trading and clearing, cash equity trading, fixed income, currency, and commodities trading. The company was founded by Gordon S. Macklin in 1971 and is headquartered in New York, NY.

Nasdaq Inc - Ordinary Shares - 144A

Nasdaq Inc

Nasdaq Inc. is currently a focal point for investors as the exchange operator navigates significant market-structure shifts, including proposals for extended trading hours and the increasing integration of tokenized assets. The community is actively debating the company's valuation alongside broader concerns regarding IPO pipelines, AI-driven market volatility, and the potential impact of central bank policies on trading volumes.

Index Coop is a decentralized autonomous organization (DAO) that builds structured DeFi products and strategy tokens. Index Coop offers a suite of sector index products, leverage and inverse products, and yield-generating products. The product suite runs on Set Protocol, an audited, self-custodial DeFi tool that allows for the creation and management of Ethereum-based (or ERC-20) tokens. Changes to the DAO are voted on by the owners of a governance token called INDEX and then implemented by a team of developers. INDEX holders wield voting power on a 1:1 basis, meaning one token equals one vote.

Index Cooperative

Index Cooperative is seeing heightened community engagement driven by its status as a microcap token with high volatility potential and expectations for a major breakout. Investors are actively discussing the project's DeFi utility and low market cap, with many users coordinating to boost volume and drive price momentum.

Tidal Trust II - YieldMax MSTR Option Income Strategy ETF

YieldMax MSTR Option Income Strategy ETF

MSTY is drawing significant community debate as investors navigate the high-volatility 

Swarmer, Inc. is an AI-driven software company, which develops software platforms and AI systems for autonomous swarm control of drones and unmanned vehicles. The firm offers STYX AI Command and Control System, MINAS Autonomy and Collaboration AI, and TRIDENT Embedded Drone Operating System. The company was founded by Alex Fink and Serhii Kuprienko in May 2023 and is headquartered in Austin, TX.

Swarmer Inc.

Swarmer Inc. is trending as retail investors speculate on its role in the autonomous drone software sector, with community discussion intensely focused on potential government contracts and the company's perceived potential to become a dominant defense industry player. The stock continues to experience high volatility and strong retail interest, driven by ongoing geopolitical tensions and the narrative that its battle-tested swarm technology represents a critical advancement in modern military warfare.

Unleash Jugs

JUGS is gaining traction as a new cryptocurrency that has captured the attention of retail traders, who are actively discussing its potential for volatility and price appreciation. The community is largely focused on the token's low holder count and concentrated supply, which many investors view as a catalyst for potential momentum or a squeeze.

Optical Cable Corp. engages in the business of manufacturing fiber optic and copper data communication cabling and connectivity solutions primarily for the enterprise market and various harsh environment, specialty markets, and the wireless carrier market offering integrated suites of high-quality products which operate as a system solution or seamlessly integrate with other components. Its products include fiber optic and copper cabling, hybrid cabling, fiber optic and copper connectors, specialty fiber optic, copper and hybrid connectors, fiber optic and copper patch cords, pre-terminated fiber optic and copper cable assemblies, racks, cabinets, datacom enclosures, patch panels, face plates, multimedia boxes, fiber optic reels, and other cable and connectivity management accessories. The company was founded on June 10, 1983 and is headquartered in Roanoke, VA.

Optical Cable Corp.

Optical Cable Corp. is trending as investors speculate on its potential as a 'backdoor' AI and data center play, with community members highlighting the stock's tight float and historical volatility. Bullish sentiment is driven by anticipation of new infrastructure contracts, while some traders remain cautious about liquidity and the lack of widespread analyst coverage.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BioXcel Therapeutics, Inc. (BTAI) Reports Q1 Loss, Lags Revenue Estimates

BioXcel Therapeutics (BTAI) delivered earnings and revenue surprises of +8.48% and -28.97%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

CorMedix (CRMD) Q1 Earnings and Revenues Beat Estimates

CorMedix (CRMD) delivered earnings and revenue surprises of +24.64% and +16.00%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Verastem (VSTM) Reports Q1 Loss, Misses Revenue Estimates

Verastem (VSTM) delivered earnings and revenue surprises of 0.00% and -16.09%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

BioXcel Therapeutics, Inc. (BTAI) Expected to Beat Earnings Estimates: Should You Buy?

BioXcel Therapeutics (BTAI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Did BioXcel Therapeutics, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Did BioXcel Therapeutics, Inc. Insiders Breach their Fiduciary Duties to Shareholders? Did BioXcel Therapeutics, Inc. Insiders Breach their Fiduciary Duties to Shareholders? PR Newswire NEW YORK, April 9, 2026 Shareholders are encouraged to contact the firm to discuss their rights and options at no...

Why Are BioXcel Therapeutics Shares Down Friday?

BioXcel Therapeutics shares fall after a rally as BXCL501 Phase 2 data show promise for treating opioid withdrawal symptoms.read more...

Defense, Biotech, and Aerospace Stories Dominate

Markets are opening Thursday with a mix of defense innovation, biotech progress, aerospace supply chain momentum, and turnaround earnings, highlighting how technology and strategic manufacturing continue to drive investor attention across several sectors. From next-generation biomaterials to counter-drone systems and aerospace electronics, the latest corporate developments suggest continued capital flow toward industries tied to national security, healthcare innovation, and advanced manufacturing. $KBLB, $IBO, $GXAI, $MOBX, $BTAI, $ALTO

BTAI Stock Gained 5% Today - What's The Latest On Its Opioid Withdrawal Treatment? 

Equity

BioXcel announced positive Phase 2 results for evaluating treatment for opioid withdrawal symptoms.

BioXcel Files SNDA To Expand IGALMI Label For At-Home Setting

(RTTNews) - BioXcel Therapeutics, Inc. (BTAI) said on Tuesday that it has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration for IGALMI, seeking approval...

Halper Sadeh LLC Encourages BioXcel Therapeutics, Inc. Shareholders to Contact the Firm to Discuss Their Rights

Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of BioXcel Therapeutics, Inc. (NASDAQ: BTAI) breached their fiduciary duties to shareholders. If...

BioXcel Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of artificial intelligence solutions in neuroscience and immuno-oncology. It also focuses on utilizing technology and research to develop therapeutics solutions. The company was founded by Vimal D. Mehta on March 29, 2017 and is headquartered in New Haven, CT.

Current Price	$1.13
Prev Close	$1.14
Open	$1.15
Dividend Yield	0.00%
50-Day Moving Average	$1.23
Beta	1.52
Avg. Volume	1.09M
PE Ratio	-0.18

52-Week High	$8.08
52-Week Low	$1.01
Market Capitalization	$34.89M
EPS (Annual)	-$5.73
Price to Book	-0.29
Revenue Per Employee	$22,137.93

BTAI
BioXcel Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Latest BTAI News

BTAIBioXcel Therapeutics Inc